Hepatitis E virus infection-triggered intrahepatic cholestasis: A case report.

IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY
Stephan Drexler, Frederic Haedge, Susanne N Weber, Marcin Krawczyk, Matthias S Matter, Carol I Geppert, Achim Weber, Bruno Stieger, Christian Trautwein, Andreas E Kremer
{"title":"Hepatitis E virus infection-triggered intrahepatic cholestasis: A case report.","authors":"Stephan Drexler, Frederic Haedge, Susanne N Weber, Marcin Krawczyk, Matthias S Matter, Carol I Geppert, Achim Weber, Bruno Stieger, Christian Trautwein, Andreas E Kremer","doi":"10.4254/wjh.v17.i4.92426","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Genetic disorders affecting hepatobiliary transporters can be triggered by various factors, resulting in marked cholestasis.</p><p><strong>Case summary: </strong>We report two patients who experienced a severe episode of intrahepatic cholestasis triggered by an acute hepatitis E virus infection. Following an extensive clinical examination that ruled out common causes of cholestatic liver damage, we conducted next-generation sequencing to determine the genetic profiles of the patients. The analysis revealed several known and unknown variants in genes associated with hepatobiliary transporters and bile salt regulation, including <i>ATP8B1</i>, <i>ABCB11</i>, <i>ABCB4</i>, <i>MYO5B</i>, and <i>FXR</i>. For a comprehensive understanding of the pathophysiology, we performed ClinVar analysis and utilized PolyPhen for bioinformatic prediction of functional impact. Both patients exhibited rapid symptom improvement and a decrease in hyperbilirubinemia when treated with either rifampicin or bezafibrate.</p><p><strong>Conclusion: </strong>Our findings introduce hepatitis E viral infection as a novel trigger for intrahepatic cholestasis, and we categorize the significance of the various genetic variants based on the current state of research.</p>","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":"17 4","pages":"92426"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038418/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v17.i4.92426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Genetic disorders affecting hepatobiliary transporters can be triggered by various factors, resulting in marked cholestasis.

Case summary: We report two patients who experienced a severe episode of intrahepatic cholestasis triggered by an acute hepatitis E virus infection. Following an extensive clinical examination that ruled out common causes of cholestatic liver damage, we conducted next-generation sequencing to determine the genetic profiles of the patients. The analysis revealed several known and unknown variants in genes associated with hepatobiliary transporters and bile salt regulation, including ATP8B1, ABCB11, ABCB4, MYO5B, and FXR. For a comprehensive understanding of the pathophysiology, we performed ClinVar analysis and utilized PolyPhen for bioinformatic prediction of functional impact. Both patients exhibited rapid symptom improvement and a decrease in hyperbilirubinemia when treated with either rifampicin or bezafibrate.

Conclusion: Our findings introduce hepatitis E viral infection as a novel trigger for intrahepatic cholestasis, and we categorize the significance of the various genetic variants based on the current state of research.

戊型肝炎病毒感染引发肝内胆汁淤积1例报告。
背景:影响肝胆转运蛋白的遗传性疾病可由多种因素引发,导致明显的胆汁淤积。病例总结:我们报告了两例由急性戊型肝炎病毒感染引发的严重肝内胆汁淤积的患者。经过广泛的临床检查,排除了胆淤积性肝损伤的常见原因,我们进行了下一代测序,以确定患者的遗传谱。分析揭示了几个已知和未知的与肝胆转运蛋白和胆盐调节相关的基因变异,包括ATP8B1、ABCB11、ABCB4、MYO5B和FXR。为了全面了解病理生理学,我们进行了ClinVar分析,并利用PolyPhen进行功能影响的生物信息学预测。两名患者在接受利福平或贝扎贝特治疗时均表现出症状的快速改善和高胆红素血症的减少。结论:我们的研究结果介绍了戊型肝炎病毒感染是肝内胆汁淤积的一种新的触发因素,并根据目前的研究状况对各种遗传变异的意义进行了分类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Hepatology
World Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.10
自引率
4.20%
发文量
172
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信